Psybio Therapeutics Corporation (CE) (PSYBF)
USOTC
PsyBio Therapeutics Increases Intellectual Property Portfolio with Filing of Novel Genetic Optimization Pathways for Psychedelic Medication Biosynthesis Patent portfolio now includes four pending...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 31175 | 1.0E-6 | CS |
12 | -0.020999 | -99.9952380952 | 0.021 | 0.021 | 1.0E-6 | 17297 | 0.00245452 | CS |
26 | -9.9E-5 | -99 | 0.0001 | 0.021 | 1.0E-6 | 11426 | 0.0020433 | CS |
52 | -0.004849 | -99.9793814433 | 0.00485 | 0.021 | 1.0E-6 | 20599 | 0.01058094 | CS |
156 | -0.186249 | -99.9994630872 | 0.18625 | 0.224 | 1.0E-6 | 31688 | 0.06712391 | CS |
260 | -0.305099 | -99.9996722386 | 0.3051 | 0.79 | 1.0E-6 | 37829 | 0.15889823 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約